PFE (Pfizer) How high will it go? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go?

PFE 24.71

+0.2%

9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Lynn	7/14/2018 12:40:23 AM
	of 9523

Pharma Stock Roundup: PFE to Split Into 3 Units, J&J to Pay $4.7B in Talc Lawsuit Zacks Equity Research July 13, 2018 [Only PFE sections here, remainder snipped--check link to read the entire new item] *Pfizer to Re-Organize Business Units: Pfizer is re-organizing its business into three business segments, separating its consumer healthcare business into a standalone unit. Beginning 2019, Pfizer will report under three new business units — Innovative Medicines, Established Medicines and Consumer Healthcare. Presently, Pfizer has two reporting segments namely Innovative Health and Essential Health. The present Innovative Health unit will be called the Innovative Medicines unit and will now include biosimilars and a new hospital business unit for anti-infectives and sterile injectables — both of which are presently reported under Essential Health. The Essential Health unit will now be renamed to Established Medicines. This unit will include Pfizer’s legacy brands that have lost or will lose market exclusivity. (Read more: Pfizer to Reorganize Business Into Three New Units). [snip] Trump Slams Pfizer for Price Hikes; Pfizer Defers Increases:* In a tweet, President Donald Trump slammed Pfizer for raising prices of several of its prescription drugs, effective from Jul 1. Trump said Pfizer and other U.S. drugmakers should be “ashamed” that they had raised drug prices for “no reason.” The tweet also said that by raising drug prices in the United States, these drug companies were offering “bargain basement prices” overseas. He warned that the administration will respond. A day after this tweet was published, Pfizer issued a statement saying it will defer the price increases until the President’s drug pricing blueprint goes into effect or until the end of the year, whichever is earlier. finance.yahoo.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next